![Wen Zhi Tian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 26 M $ au 31/05/2026
Wen Zhi Tian founded ImmuneOnco Biopharmaceuticals (Shanghai), Inc. in 2015, where he is working as Chairman, CEO & Chief Scientific Officer from 2015.
Dr. Tian also founded ImmuneOnco Biotechnology (Shanghai) Co., Ltd.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 70 482 990 ( 16,76 % ) | 26 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Directeur Général | 01/06/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
ImmuneOnco Biotechnology (Shanghai) Co. Ltd.
 ImmuneOnco Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a research-driven biotechnology company that develops cancer immunotherapies products | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
ImmuneOnco Biotechnology (Shanghai) Co. Ltd.
ImmuneOnco Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a research-driven biotechnology company that develops cancer immunotherapies products | Commercial Services |
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
 ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
